647
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Response to the letter to the editor regarding the article “Weight of evidence evaluation for chemical-induced immunotoxicity for PFOA and PFOS: findings from an independent panel of experts” by Garvey et al. (2023)

, , , , , , , , , , & show all
Pages 438-439 | Received 07 Jul 2023, Accepted 17 Jul 2023, Published online: 25 Aug 2023
 

Declaration of interest

All authors of Garvey et al. (Citation2023) had complete control over this response to Post (Citation2023) and agree to this response. No authors received funding for preparing this response to Post (Citation2023). The sponsor of the original manuscript had no input or review of this response.

Notes

1 Notably, the Draft for Public Comment U.S. Environmental Protection Agency’s (USEPA) revised technical support documents for PFOA and PFOS maximum contaminant level goals, released in March 2023, still considered the immune endpoint for the point of departure derivation for both compounds, however, this endpoint was no longer used by the agency as the ultimate critical effect for PFOS and was used only in combination with developmental and cardiovascular effects for PFOA (see https://www.epa.gov/system/files/documents/2023-03/MAIN_Proposed%20MCLG%20for%20PFOA%20in%20Drinking%20Water_3.9.23_For%20Proposal.pdf and https://www.epa.gov/system/files/documents/2023-03/MAIN_Proposed%20MCLG%20for%20PFOS%20in%20Drinking%20Water_3.9.23_For%20Proposal_0.pdf).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.